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DURING orthotopic liver transplantation (OL T) a large transfusion of different 
blood components is frequently necessary. 
From 1981 to 1985 at the University Health 
Center in Pittsburgh, 4,318 units of RBCs and 
4,788 units of platelets were administered 
during 366 OL T performed in adults. This 
results in a mean of 25 units of RBCs and 30 
units of platelets per operation.1 
The majority of adult liver transplant 
patients receive multiple transfusions of whole 
blood and/or blood components during their 
pretransplant course because of complications 
relating to their original disease. The exposure 
of these patients to different antigens from 
random donors facilitates the development of 
alloimmunization. The heightened alloim-
mune state can be identified by preoperative 
values of panel reacting antibodies (PRA). 
Since platelets possess the HLA antigens of 
donor specificity, platelets may function as 
the target of host antibodies. resulting in 
platelet alteration and subsequent dysfunc-
ti<>n. Thus. the effect of alloimmunization on 
platelet function may be one of the factors 
responsible for significant blood loss after 
large transfusions of different blood compo-
nents. 
In this retrospective study we compared 
blood loss and platelet transfusion during 
OL T with preoperative alloimmuniiation 
against random donor antigens, indicated by 
PRA values. 
PATIENTS AND METHODS 
Two aroups of patients were randomly ch06en out of 
127 liver transplants performed from January 1984 to the 
end or December 1986 at the Univc:n;ity Health Center in 
Pituburgh. 
Group I (26 patients) had PRA values of 0% and aroup 
2 (20 patients) bad PRA values of 70% or bigher. 80th 
aroups were: matched for age:. weight. and diagnosis. 
Patients with important previous lur,ery or intraopera-
tive events. eventually causing extraordinary bleeding. 
were excluded from the IIudy. 
The intraoperative transfusion of R BC, fresh frozen 
plasma. platelets. and cryoprccipitates was examined. In 
addition. the helllOCOlllulative profile was asscssccl usinl 
hematocrit, platelet count. fibrinolen. prothrombin time 
(PT) and activated partial thromboplastin time (APlT). 
It should be emphasized that heparin was never used pre-
or intraoperatively. 
Statistical analysis of differences between the match 
Iroups was done usin, a Macintosh microcomputer (Ap-
ple Computer. Cupertino. CAl and Statwork software 
(Cricket Software, PAl; tbe Student's t test was used. 
RESULTS 
The hemocoagulative values (mean j; SO) 
showed no difference between the two groups 
at the beginning of the OL T (Table 1). Table 
2 reports the intraoperative amounts (mean :t 
SO) of blood components transfused during 
OL T in both groups. Group 2, with PRA 
values equal or higher than 70%, needed sig-
nificantly more transfusions of all blood com-
ponents compared with group 1. The only 
exception was for whole blood, which was very 
rarely used intraoperatively in our experience. 
Table 3 shows the hematologic values 
(mean ± SO) for both groups at the end of 
surgery. It can be seen that the larger quantity 
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T.bl. 1. ,.tient Group.nd Preoper.tlv. Cliniclll P.,.m,'.r. 
A'J" 
Iyr) 
Weight 
Ikg) 
Hematocrit 
1'1(,) 
Plet.t count 
h< 10'/mm'l 
Fibrinogen 
Img/cl.1 
PT 
1.1 
APTI (., 
(;. ..... ' 
PRKM~ 14.1 
64.4 ~ 19.2 
29.7 t 6.4 
1 14.76 ~ 76.80 
229.6 ~ 163.0 
17.2 t 10.4 
45.9 ~ 26.7 
(;."",,2 
39.0 ~ 12.4 NS 
54.3 ~ 16.8 NS 
26.9 ~ 4.8 NS 
I 10.0 ~ 66.6 NS 
187.8 ~ 83.6 NS 
15.8 ~ 3.0 NS 
43.6 ~ 11.2 NS 
T.bI.2. Intraoper.tlv. Tr'Mfuslon 
(;."",,1 
RBC B.B ~ 10.7 
F,esh frozen plasm. 9.1 ~ 12.2 
Plet.,. 7.8 ~ B.7 
Cryoprecipitates 1.4 t 2.2 
Whole blood 1.6 ~ 2.4 
of intraoperatively transfused blood compo-
nents in group 2 (Table 2) is accompanied by 
a coagulation profile that is considerably 
worse than for group 1. 
DISCUSSION AND CONCLUSION 
Clinical experience shows that coagulation 
problems and the intraoperative transfusion of 
large volumes of blood negatively influence 
surgical outcome and patient survivaJ.2 Our 
data from liver transplant patients underline 
(;."",,2 Signif1canoe 
30.7 ~ 32.6 P - .01 
28.5 t 31.6 P - .019 
20.0 ~ 20.5 p- .024 
11.6 t 11.9 p- .002 
1.B ~ 4. I NS 
these observations. Although both groups of 
patients had similar preoperative hemocoagu-
lative profiles (Table 1), group 2 with higher 
PRA values showed significantly worsened 
end surgery values. The degree of postopera-
tive coagulation problems is directly related to 
the amount of blood and blood components 
transfused intraoperatively. 
Our results also indicate a close and signifi-
cant correlation between previous alloim.mu-
nization to random antigens (as indicated by 
T.bIe 3. End· Surgery Hemeto6oglc '.remet.,. 
~1 ~O ~ 
Hematocrit 
('1(,1 32.1t4.7 2B.2 ~ 4.7 p- .01 
P1IIt.t count 
(x 10'/rnm'l 143.5 ~ 74.2 71.2 ~ 46.6 P - .001 
Fibrinogen 
Img/cl.1 165.8:t 84.9 135.0 ~ 49.3 NS 
PT 
1.1 16.0 ~ 2.6 16.2 ~ 4.0 NS 
APTT 
1.1 3B.3 t 8.4 ..... 8 ~ 7.7 p- .01 
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PLATELET TRANSFUSION IN LIVER TRANSPlANTATION 
PRA levels) and the necessity to transfuse 
blood components during OL T. Patients with 
PRA values above 70% needed significantly 
higher amounts of blood factors than patients 
with no detectable alloimmunization at the 
time of transplantation (PRA - 0%). These 
findings underline the relation of alloimmuni-
zation to the coagulation status in OLT 
patients and indicate that extraordinary blood 
loss during OL T may be reduced by transfus-
1089 
ing platelets matched to the patient's HLA 
type.) 
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